Resultados: 19

    Recommandations françaises du Comité de cancérologie de l’AFU - actualisation 2020–2022: tumeurs de la voie excrétrice urinaire supérieure

    Prog. urol. (Paris); 30 (12), 2020
    The purpose was to propose an update of the French guidelines from the national committee ccAFU on upper tract urothelial carcinomas (UTUC). A systematic Medline search was performed between 2018 and 2020, as regards diagnosis, options of treatment and follow-up of UTUC, to evaluate different references...

    Use of chest imaging in COVID-19: a rapid advice guide

    Since its identification in China in December 2019, the novel coronavirus COVID-19 has rapidly evolved into a pandemic. COVID-19 manifests with non-specific respiratory symptoms of variable severity and may require advanced respiratory support. The diagnosis of COVID-19 is currently confirmed by laborato...

    Communicating risk in public health emergencies: a WHO guideline for emergency risk communication (ERC) policy and practice

    During public health emergencies, people need to know what health risks they face, and what actions they can take to protect their health and lives. Accurate information provided early, often, and in languages and channels that people understand, trust and use, enables individuals to make choices and tak...

    Global accelerated action for the health of adolescents (AA-HA!): guidance to support country implementation

    The AA-HA! guidance aims to assist governments in deciding what they plan to do – and how they plan to do it – as they respond to the health needs of adolescents in their countries. It is intended as a reference document for national-level policy-makers and programme managers to assist them in planni...

    Hormonal contraceptive eligibility for women at high risk of HIV

    The World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was recognized as a critical one, particularly for sub-Saharan Africa, where women have a high lifetime ...

    Selected practice recommendations for contraceptive use

    This document is part of the process for improving the quality of care in family planning. Specifically, it is one of two evidence-based cornerstones (guidance documents) of the World Health Organization’s (WHO’s) initiative to develop and implement family planning guidelines for national programmes....

    WHO recommendations on antenatal care for a positive pregnancy experience

    Endorsed, by the UN Secretary-General, this is a comprehensive WHO guideline on routine ANC for pregnant women and adolescent girls. It aims to complement existing WHO guidelines on the management of specific pregnancy-related complications. The guidance aims to capture the complex nature of the issues s...

    WHO guidelines on the management of health complications from female genital mutilation

    These guidelines are intended primarily for health-care professionals involved in the care of girls and women who have been subjected to any form of female genital mutilation (FGM). This document also provides guidance for policy-makers, health-care managers and others in charge of planning, developing a...

    Medical eligibility criteria for contraceptive use

    This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, presents current WHO guidance on the safety of various contraceptive methods for use in the context of spe...

    Guideline: managing possible serious bacterial infection in young infants when referral is not feasible

    Infections are responsible for about one fifth of the world’s annual 2.7 million neonatal deaths. In South Asia and sub-Saharan Africa about one quarter of all neonatal deaths are due to infections. Many sick infants only have non-specific signs, and thus are not recognized to have infection. Even when...